Gilead Sciences Inc

GILD Real Time Price USD

N/A

...

Overview

Financials

Forecast

Insiders

Institutions

Government

Ownership

$GILD is featured in our Shelley Moore Capito strategy.

See All Strategies

Income

Balance Sheet

Cash Flow

Revenue Breakdown

Congress Trading

Recent trades of GILD by members of U.S. Congress

Politician	Type	Traded
Jefferson Shreve House / R	Purchase $15,001 - $50,000	Mar. 31, 2025
Carol D. Miller House / R	Purchase $1,001 - $15,000	Mar. 10, 2025
Josh Gottheimer House / D	Purchase $1,001 - $15,000	Mar. 07, 2025
Marjorie Taylor Greene House / R	Purchase $1,001 - $15,000	Dec. 24, 2024
Tommy Tuberville Senate / R	Purchase $1,001 - $15,000	May. 10, 2024
Tommy Tuberville Senate / R	Purchase $1,001 - $15,000	May. 10, 2024
Tommy Tuberville Senate / R	Purchase $1,001 - $15,000	May. 10, 2024
Tommy Tuberville Senate / R	Sale (Full) $1,001 - $15,000	May. 08, 2024
Tommy Tuberville Senate / R	Purchase $1,001 - $15,000	Apr. 05, 2024
Tommy Tuberville Senate / R	Sale (Full) $1,001 - $15,000	Apr. 03, 2024
HON. GREG STANTON House / D	Sale $1,001 - $15,000	Oct. 24, 2023
HON. GREG STANTON House / D	Purchase $1,001 - $15,000	Sep. 26, 2023
Daniel S. Goldman House / D	Sale $15,001 - $50,000	Jul. 12, 2023
Zoe Lofgren House / D	Sale $1,001 - $15,000	May. 25, 2023
Daniel S. Goldman House / D	Purchase $15,001 - $50,000	Mar. 06, 2023
Zoe Lofgren House / D	Purchase $1,001 - $15,000	Sep. 09, 2022
Tommy Tuberville Senate / R	Sale (Full) $1,001 - $15,000	Jan. 13, 2022
Jerry Moran Senate / R	Sale (Full) $1,001 - $15,000	Dec. 21, 2021
Jerry Moran Senate / R	Sale (Full) $1,001 - $15,000	Dec. 21, 2021
Carol D. Miller House / R	Sale $15,001 - $50,000	Nov. 10, 2021
Sara Jacobs House / D	Sale $15,001 - $50,000	Apr. 09, 2021
Marjorie Taylor Greene House / R	Purchase $1,001 - $15,000	Jan. 21, 2021
Gilbert Ray Cisneros, Jr. House / D	Sale $1,001 - $15,000	Dec. 22, 2020
Dean Phillips House / D	Sale $1,001 - $15,000	Dec. 18, 2020
Dean Phillips House / D	Purchase $1,001 - $15,000	Sep. 23, 2020
Ed Perlmutter House / D	Sale $1,001 - $15,000	Sep. 01, 2020
Jerry Moran Senate / R	Purchase $1,001 - $15,000	Aug. 21, 2020
Ed Perlmutter House / D	Purchase $1,001 - $15,000	Jul. 15, 2020
William R. Timmons IV House / R	Sale $1,001 - $15,000	Jun. 29, 2020
Roger Marshall House / R	Purchase $1,001 - $15,000	May. 07, 2020
Roger Marshall House / R	Purchase $1,001 - $15,000	May. 05, 2020
Roger Marshall House / R	Purchase $1,001 - $15,000	May. 04, 2020
Gilbert Ray Cisneros, Jr. House / D	Purchase $1,001 - $15,000	Mar. 18, 2020
Mikie Sherrill House / D	Sale $1,001 - $15,000	Feb. 20, 2020
Gilbert Ray Cisneros, Jr. House / D	Purchase $1,001 - $15,000	Feb. 07, 2020
Mikie Sherrill House / D	Purchase $1,001 - $15,000	Jan. 21, 2020
Mikie Sherrill House / D	Sale $1,001 - $15,000	Dec. 18, 2019
Earl Blumenauer House / D	Purchase $1,001 - $15,000	Oct. 25, 2019
Jerry Moran Senate / R	Purchase $1,001 - $15,000	Sep. 25, 2019
Jerry Moran Senate / R	Purchase $1,001 - $15,000	Sep. 25, 2019
Bill Flores House / R	Purchase $1,001 - $15,000	Sep. 19, 2019
Dean Phillips House / D	Sale $1,001 - $15,000	May. 13, 2019
Bill Flores House / R	Sale $1,001 - $15,000	May. 08, 2019
Mikie Sherrill House / D	Sale $1,001 - $15,000	Apr. 18, 2019
Bill Flores House / R	Purchase $1,001 - $15,000	Mar. 25, 2019
Shelley Moore Capito Senate / R	Sale (Full) $1,001 - $15,000	Mar. 11, 2019
Dean Phillips House / D	Sale $1,001 - $15,000	Jan. 04, 2019
Greg Gianforte House / R	Purchase $15,001 - $50,000	Dec. 21, 2018
Dean Heller Senate / R	Sale (Full) $1,001 - $15,000	Dec. 06, 2018
John A. Yarmuth House / D	Sale $1,001 - $15,000	Nov. 26, 2018

GILD Stock Insider Trading Activity

Name	Type	Shares	Price	Shares Held	Date	Reported

GILD Stock Institutional Owners

Investor	Shares	Change in Shares	Market Value	Date	Reported

GILD Derivatives Institutional Owners

Investor	Type	Shares	Change in Shares	Market Value	Date	Reported

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by GILD's directors and management

Corporate Lobbying

Government lobbying spending instances

$1,662,000 Apr 21, 2025 Issue: Trade (domestic/foreign) Health Issues Medicare/Medicaid Copyright/Patent/Trademark Budget/Appropriations Taxation/Internal Revenue Code
$2,440,000 Jan 21, 2025 Issue: Trade (domestic/foreign) Health Issues Medicare/Medicaid Copyright/Patent/Trademark Budget/Appropriations Taxation/Internal Revenue Code
$2,050,000 Oct 21, 2024 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
$1,530,000 Jul 22, 2024 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
$2,740,000 Apr 18, 2024 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
$1,680,000 Jan 23, 2024 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
$2,390,000 Oct 20, 2023 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
$1,440,000 Jul 20, 2023 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
$1,490,000 Apr 14, 2023 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
$2,520,000 Oct 20, 2022 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
$1,372,000 Jul 20, 2022 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
$2,620,000 Apr 20, 2022 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
$1,980,000 Jan 19, 2022 Issue: None
$2,290,000 Oct 20, 2021 Issue: None
$1,380,000 Jul 20, 2021 Issue: None
$2,530,000 Apr 20, 2021 Issue: None
$1,510,000 Jan 20, 2021 Issue: None
$1,810,000 Oct 20, 2020 Issue: None
$1,260,000 Jul 20, 2020 Issue: None
$2,450,000 Apr 20, 2020 Issue: None
$1,300,000 Jan 21, 2020 Issue: None
$1,480,000 Oct 21, 2019 Issue: Budget/Appropriations Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Trade (domestic/foreign)
$1,080,000 Jul 22, 2019 Issue: Indian/Native American Affairs Budget/Appropriations Medicare/Medicaid Veterans Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
$1,860,000 Apr 23, 2019 Issue: Indian/Native American Affairs Budget/Appropriations Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Veterans Copyright/Patent/Trademark Health Issues
$700,000 Jan 22, 2019 Issue: Medicare/Medicaid Defense Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues Veterans Budget/Appropriations Indian/Native American Affairs Taxation/Internal Revenue Code
$680,000 Oct 22, 2018 Issue: Medicare/Medicaid Veterans Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Indian/Native American Affairs Budget/Appropriations
$800,000 Jul 20, 2018 Issue: Indian/Native American Affairs Budget/Appropriations Medicare/Medicaid Foreign Relations Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Veterans Trade (domestic/foreign)
$810,000 Apr 20, 2018 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Veterans Foreign Relations Indian/Native American Affairs Budget/Appropriations Taxation/Internal Revenue Code
$900,000 Jan 22, 2018 Issue: Indian/Native American Affairs Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Veterans Foreign Relations
$810,000 Oct 20, 2017 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Veterans Copyright/Patent/Trademark Foreign Relations Trade (domestic/foreign) Taxation/Internal Revenue Code Pharmacy Indian/Native American Affairs
$790,000 Jul 20, 2017 Issue: Pharmacy Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Veterans Trade (domestic/foreign) Indian/Native American Affairs Foreign Relations Taxation/Internal Revenue Code
$1,050,000 Apr 20, 2017 Issue: Law Enforcement/Crime/Criminal Justice Pharmacy Medicare/Medicaid Foreign Relations Health Issues Copyright/Patent/Trademark Indian/Native American Affairs Veterans Trade (domestic/foreign) Taxation/Internal Revenue Code Budget/Appropriations
$960,000 Jan 19, 2017 Issue: Medicare/Medicaid Veterans Health Issues Copyright/Patent/Trademark Budget/Appropriations Foreign Relations Trade (domestic/foreign) Law Enforcement/Crime/Criminal Justice Pharmacy
$780,000 Oct 20, 2016 Issue: Law Enforcement/Crime/Criminal Justice Pharmacy Medicare/Medicaid Foreign Relations Veterans Health Issues Copyright/Patent/Trademark Budget/Appropriations Trade (domestic/foreign) Defense
$760,000 Jul 19, 2016 Issue: Medicare/Medicaid Foreign Relations Health Issues Pharmacy Trade (domestic/foreign) Veterans Defense Budget/Appropriations Copyright/Patent/Trademark
$980,000 Apr 18, 2016 Issue: Science/Technology Pharmacy Medicare/Medicaid Foreign Relations Veterans Health Issues Trade (domestic/foreign) Defense Budget/Appropriations Copyright/Patent/Trademark
$890,000 Jan 20, 2016 Issue: Science/Technology Pharmacy Medicare/Medicaid Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark Veterans Foreign Relations Defense Budget/Appropriations
$700,000 Oct 19, 2015 Issue: Pharmacy Medicare/Medicaid Veterans Health Issues Defense Trade (domestic/foreign) Foreign Relations Budget/Appropriations Copyright/Patent/Trademark Science/Technology
$550,000 Jul 20, 2015 Issue: Science/Technology Pharmacy Medicare/Medicaid Veterans Health Issues Copyright/Patent/Trademark Defense Foreign Relations Budget/Appropriations Trade (domestic/foreign)
$800,000 Apr 21, 2015 Issue: Medicare/Medicaid Health Issues Veterans Trade (domestic/foreign) Defense Copyright/Patent/Trademark
$620,000 Jan 19, 2015 Issue: Medicare/Medicaid Health Issues Veterans Trade (domestic/foreign) Defense Copyright/Patent/Trademark
$640,000 Oct 17, 2014 Issue: Medicare/Medicaid Health Issues Veterans Trade (domestic/foreign) Copyright/Patent/Trademark
$820,000 Jul 15, 2014 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
$810,000 Apr 18, 2014 Issue: Medicare/Medicaid Veterans Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark
$550,000 Jan 21, 2014 Issue: Health Issues Copyright/Patent/Trademark Veterans Medicare/Medicaid
$540,000 Oct 21, 2013 Issue: Health Issues Copyright/Patent/Trademark Veterans Medicare/Medicaid
$623,000 Aug 05, 2013 Issue: Health Issues Copyright/Patent/Trademark
$510,000 Jul 19, 2013 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
$320,000 Jan 22, 2013 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
$370,000 Oct 22, 2012 Issue: Health Issues
$340,000 Jul 20, 2012 Issue: Health Issues
$560,000 Apr 20, 2012 Issue: Health Issues
$400,000 Jan 20, 2012 Issue: Health Issues
$370,000 Oct 20, 2011 Issue: Health Issues
$390,000 Jul 20, 2011 Issue: Health Issues
$500,000 Apr 20, 2011 Issue: Health Issues
$340,000 Jan 20, 2011 Issue: Health Issues
$350,000 Oct 20, 2010 Issue: Health Issues
$350,000 Jul 20, 2010 Issue: Health Issues
$480,000 Apr 20, 2010 Issue: Health Issues
$370,000 Jan 20, 2010 Issue: Health Issues
$350,000 Oct 20, 2009 Issue: Health Issues
$290,000 Jul 20, 2009 Issue: Health Issues
$270,000 Apr 20, 2009 Issue: Health Issues
$240,000 Jan 09, 2009 Issue: Health Issues
$240,000 Oct 28, 2008 Issue: Health Issues
$260,000 Oct 28, 2008 Issue: Health Issues
$260,000 Jun 25, 2008 Issue: Health Issues
$280,000 Feb 14, 2008 Issue: Health Issues
$380,000 Aug 14, 2007 Issue: Health Issues
$355,000 Feb 13, 2007 Issue: Health Issues
$455,000 Aug 14, 2006 Issue: Health Issues
$180,000 Apr 06, 2006 Issue: Health Issues
$60,000 Aug 24, 2005 Issue: Medical/Disease Research/Clinical Labs
$140,000 Aug 22, 2005 Issue: Health Issues
$20,000 Aug 15, 2005 Issue: Trade (domestic/foreign)
$40,000 Feb 09, 2005 Issue: None
$40,000 Sep 08, 2004 Issue: Health Issues
$100,000 Apr 12, 2004 Issue: Health Issues Pharmacy
$100,000 Aug 15, 2003 Issue: Health Issues Pharmacy
$100,000 Mar 03, 2003 Issue: Health Issues Pharmacy
$100,000 Aug 14, 2002 Issue: Health Issues Pharmacy
$60,000 Feb 14, 2002 Issue: Health Issues Pharmacy

Corporate Lobbying

Estimated quarterly lobbying spending

Revenue Breakdown

GILD Revenue by Segment or Geography

By Segment

By Geography

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard

GILD Income Statement

GILD Balance Sheet

GILD Cash Flow

U.S. Patents

New patents grants

Patent Title: Thiadiazole irak4 inhibitors Aug. 13, 2024
Patent Title: Antiviral compounds Aug. 06, 2024
Patent Title: Bridged tricyclic carbamoylpyridone compounds and uses thereof Aug. 06, 2024
Patent Title: Diacylglycerol kinase modulating compounds Aug. 06, 2024
Patent Title: Hiv vaccines and methods of using Aug. 06, 2024
Patent Title: Quinoline derivatives Aug. 06, 2024
Patent Title: 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections Jul. 30, 2024
Patent Title: Substituted eneoxindoles and uses thereof Jul. 16, 2024
Patent Title: Pentacyclic derivatives as zika virus inhibitors Jul. 16, 2024
Patent Title: Crystalline forms of (s)-2-ethylbutyl 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy) (phenoxy) phosphoryl)amino)propanoate Jul. 09, 2024
Patent Title: Phospholipid compounds and uses thereof Jul. 09, 2024
Patent Title: Antiviral compounds Jul. 09, 2024
Patent Title: Bridged tricyclic carbamoylpyridone compounds and uses thereof Jul. 02, 2024
Patent Title: Methods of preparing 1′-cyano nucleosides Jun. 18, 2024
Patent Title: Diacylglycerol kinase modulating compounds Jun. 04, 2024
Patent Title: Triazole carbamate pyridyl sulfonamides as lpa receptor antagonists and uses thereof Jun. 04, 2024
Patent Title: Therapeutic compounds May. 28, 2024
Patent Title: Blister pack May. 28, 2024
Patent Title: Antibodies that target hiv gp120 and methods of use May. 21, 2024
Patent Title: Blister pack May. 21, 2024
Patent Title: Lpa receptor antagonists and uses thereof May. 14, 2024
Patent Title: Inhibitors of peptidylarginine deiminases May. 07, 2024
Patent Title: Diacylglycerol kinase modulating compounds May. 07, 2024
Patent Title: Substituted pyrrolo[1,2-b]pyridazines as bifunctional degraders of interleukin-1 receptor-associated kinases May. 07, 2024
Patent Title: Compositions comprising an rna polymerase inhibitor and cyclodextrin for treating viral infections May. 07, 2024
Patent Title: Remdesivir treatment methods May. 07, 2024
Patent Title: Phospholipid compounds and uses thereof Apr. 23, 2024
Patent Title: Combination therapy comprising an acc inhibitor Apr. 23, 2024
Patent Title: Combination mcl-1 inhibitors with anti-cancer agents Apr. 16, 2024
Patent Title: Capsid inhibitors for the treatment of hiv Apr. 02, 2024
Patent Title: 1′-cyano nucleoside analogs and uses thereof Mar. 26, 2024
Patent Title: Lpa receptor antagonists and uses thereof Mar. 26, 2024
Patent Title: Pharmaceutical package Mar. 26, 2024
Patent Title: Diacylglycerol kinase modulating compounds Mar. 19, 2024
Patent Title: Combination mcl-1 inhibitors with anti-body drug conjugates Mar. 19, 2024
Patent Title: Compounds and methods for treatment of viral infections Mar. 12, 2024
Patent Title: Diacylglyercol kinase modulating compounds Mar. 12, 2024
Patent Title: Substituted 6-azabenzimidazole compounds Mar. 12, 2024
Patent Title: Cd73 compounds Mar. 05, 2024
Patent Title: Pharmaceutical package Mar. 05, 2024
Patent Title: Lpa receptor antagonists and uses thereof Feb. 27, 2024
Patent Title: Cot modulators and methods of use thereof Feb. 20, 2024
Patent Title: Remdesivir treatment methods Feb. 20, 2024
Patent Title: Substituted pyridotriazine compounds and uses thereof Feb. 13, 2024
Patent Title: Substituted 6-azabenzimidazole compounds Feb. 13, 2024
Patent Title: Ikaros zinc finger family degraders and uses thereof Feb. 13, 2024
Patent Title: Interleukin-2 variant proteins fused to human igg4 fc and uses thereof Feb. 13, 2024
Patent Title: Substituted pyrido[1,2-a]pyrrolo[1,2-d]pyrazines for treating viral infections Jan. 30, 2024
Patent Title: Inhibitors of peptidylarginine deiminases Jan. 23, 2024
Patent Title: Glp-1r modulating compounds Jan. 02, 2024

Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

GILD News

Recent insights relating to GILD

CNBC Recommendations

Recent picks made for GILD stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GILD

GILD Analyst Ratings

GILD Stock Forecasts

...

... Highest Price Target
... Median Price Target
... Lowest Price Target

GILD Analyst Forecasts

Analyst	Firm	Current	Previous	Date

Frequently Asked Questions

Is $GILD stock a Buy, Sell, or Hold?
What is the price target for $GILD stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

GILD Top Shareholders

Shareholder	Shares Held

GILD Options Owners

Shareholder	Security	Underlying Shares

Frequently Asked Questions

Who owns $GILD stock?
Who owns the most shares of $GILD stock?
What funds own $GILD stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

GILD Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.

Score Breakdown

Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.